,i  #aai? ,,congress  #a/ ,session  ,h4 
,r4 #afgb  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,febru>y #bg1         
#bjbe,mr4 ,davis ( ,nor? ,c>ol9a 7=     
himself1 ,mr4 ,joyce ( ,p5nsylvania1    
,mr4 ,got!im]1 ,ms4 ,t5ney1 ,mr4 ,yakym1
 ,mr4 ,morelle1 ,mr4 ,hudson1 ,mr4 ,bean
 ( ,florida1 ,mrs4 ,mill]-,meeks1 ,mr4  
,all51 ,ms4 ,van ,duyne1 ,mr4 ,pet]s1   
,mr4 ,moore ( ,utah1 & ,mr4 ,cr5%aw7    
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,en]gy & ,comm]ce1 & 9 
addition to ! ,committee on ,ways &     
,means1 = a p]iod to be subsequ5tly     
det]m9$ by ! ,speak]1 9 ea* case =      
consid]ation ( su* provisions z fall )9 
! jurisdiction ( ! committee conc]n$  ,a
 ,,bill  ,to am5d title ,,xi ( ! ,social
 ,security ,act to protect access to    
g5etically t>get$ te*nologies4  #a4     
,%ort title ,?is ,act may be cit$ z !   
,ma9ta9+ ,inve/m5ts 9 ,new ,innovation  
,act4  #b4 ,am5dm5t to def9ition (      
qualify+ s+le s\rce drug ,section       
#aaib7;e7 ( ! ,social ,security ,act    

7#db ,u4,s4,c4 #acbj;f-#a7;e77 is       
am5d$-- 7#a7 9 p>agraph 7#a77;,a77ii71  
by ins]t+ 7or1 9 ! case ( an advanc$    
drug product 7z def9$ 9 p>agraph 7#d771 
#aa ye>s7 aft] #g ye>s2 &  7#b7 by add+ 
at ! end ! foll[+ new p>agraph3  7#d7   
,advanc$ drug product def9$ ,= purposes 
( p>agraph 7#a77;,a77ii71 ! t]m advanc$ 
drug product means a drug t incorporates
 or utilizes a g5etically t>get$        
te*nology 7z def9$ 9 section            
#ebi;,a7c77#b7 ( ! ,f$]al ,food1 ,drug1 
& ,cosmetic ,act7 t may result 9 !      
modulation 7includ+ suppression1        
up-regulation1 or activation7 ( !       
function ( a g5e or its associat$ g5e   
product4  4